September 9, 2021, was a busy day for the federal government and pharmacy stakeholders alike: Just a few hours apart, we saw significant developments in pharmacists’ COVID-19 pandemic practice authorities and prescription drug pricing. Both items yielded positive news for pharmacists and their patients.

The American Pharmacists Association (APhA) and the American Society of Health-System Pharmacists (ASHP) today hailed the introduction of bipartisan legislation in the U.S. Senate that would give tens of millions of Medicare patients in medically underserved communities access to critically needed primary health care services delivered by pharmacists.